BEST PRACTICE GUIDE: Continuous subcutaneous diabetes …

systems combine continuous glucose monitoring (CGM) with continuous subcutaneous insulin infusion and are intended to further improve glycaemic control and quality of life for people with Type 1 diabetes. Evidence suggests average HbA1c improvements of approximately 0.5% (5.5 mmol/mol) can be achieved with the addition of